Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR)

115 filings reported holding LRMR - Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2024.
Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 63.6M shares of 85.6M outstanding shares and own 74.26% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (21.2M shares), RA CAPITAL MANAGEMENT, L.P. (6.05M shares), JANUS HENDERSON GROUP PLC (4.02M shares), Blue Owl Capital Holdings LP (3.99M shares), GOLDMAN SACHS GROUP INC (3.42M shares), VANGUARD GROUP INC (2.37M shares), BlackRock Inc. (2.34M shares), Verition Fund Management LLC (1.5M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.43M shares), and CITADEL ADVISORS LLC (1.16M shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.